LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform

17/01/2023
PRESS RELEASE

Brussels, 17 January 2023 – An Industry Advisory Group (IAG) representing biotechnology across sectors, countries and through the innovation pathway has been launched to support EuropaBio’s new Biomanufacturing Platform.

The IAG includes SMEs, mid and large sized companies, plus National associations, with the aim to ensure that biomanufacturing is recognised and supported as a significant part of Europe’s economic growth in a rapidly accelerating global biomanufacturing market.

The 2023 IAG includes:

  • Audrey Bru, Lallemand (UK/FR)
  • Inga Matijosyte, LBTA (LT)
  • Matt Moran, IBEC (IRE)
  • Sarah Moundir, Novartis (CH)
  • Gwenaël Servant, Abolis (FR)
  • Sabrina Spina, Olon (IT)
  • Peter Steen Mortensen, Novozymes (DK)
  • Tineke Van hooland, Bio.be (BE)

The IAG kick starts the Biomanufacturing Platform growth in 2023, with the Biomanufacturing Policy Summit hosted on March 15 in Brussels. The Group will ensure industry-relevant definitions, vision, case studies and recommendations to policy stakeholders at national and European level so that Europe is globally competitive.

Biomanufacturing is already present within most sectors, whether product or process-based, including advanced therapies such as cell and gene therapy, food, materials and industry intermediates. It provides significant employment and economic growth, as Europe strives to meet the Green Deal and deliver advanced healthcare particularly in response to unmet needs such as those within rare diseases.

Dr Virginia Claudio, EuropaBio Senior Adviser and Programme Manager said “Biomanufacturing investments are of paramount importance for EU tech sovereignty and quality of life of EU citizens. The IAG behind the Biomanufacturing Platform brings the voices of industry and economic development for Europe and will ensure that it is always at the forefront of Europe’s policy priorities.”

EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
26/06/2025

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Read more
26/06/2025

Health Biomanufacturing: Feedstock for Preparedness and Resilience


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.